Description

Bromocriptine is a potent ergot derivative and dopamine receptor agonist with significant therapeutic applications. Its primary value lies in its ability to mimic the action of dopamine, making it a critical active pharmaceutical ingredient (API) for targeted medical treatments. This compound is essential for pharmaceutical manufacturers and research institutions developing therapies for endocrine and neurological disorders. Bromocriptine CAS NO 25614-03-3 is supplied under stringent quality control to ensure reliability for formulation and clinical use.

Application

• Pharmaceutical API: Primary use as the active ingredient in prescription medications for treating hyperprolactinemia (excessive prolactin secretion).
• Parkinson's Disease Therapy: Used in the management of Parkinson's disease symptoms as an adjunct therapy to levodopa.
• Acromegaly Treatment: Employed to reduce growth hormone levels in patients with acromegaly.
• Female Reproductive Health: Formulated in drugs to address infertility and menstrual problems associated with high prolactin.
• Neurological Research: Serves as a key reference standard and tool compound in dopaminergic pathway and receptor studies.
• Veterinary Medicine: Applied in veterinary practice for similar endocrine conditions in animals.
• Drug Development: Used in pre-clinical and formulation research for new therapeutic agents targeting dopamine D2 receptors.

Basic Information

Product Name	Bromocriptine
CAS No.	25614-03-3
Molecular Formula	C32H40BrN5O5
Molecular Weight	654.60 g/mol
Synonyms	2-Bromoergocryptine; 2-Bromo-α-ergocryptine; Bromocriptine Mesylate (salt form); CB-154; Parlodel (brand name); (5'α)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; 2-Bromoergokryptine
EINECS	247-139-1

Quality Control

Our Bromocriptine is manufactured and tested to meet the highest pharmacopeial standards, including USP and EP monographs where applicable. Every batch undergoes rigorous analytical testing for identity, purity, and impurities to ensure it is suitable for pharmaceutical use. A comprehensive Certificate of Analysis (COA) documenting all test results is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to yellowish, crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any individual impurity ≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.